FAP-directed CAR-T cells have been developed to target CAFs in several solid tumors, including mesothelioma, lung cancer, and pancreatic cancer, demonstrating antitumor activity in preclinical models [36,37,38]. The gene discussed is FAP; the disease is mesothelioma.